基于人工智能的快速无标记光学成像对弥漫性胶质瘤进行分子分类
本研究开发了DeepGlioma,一种快速(90秒内)人工智能诊断筛查系统,利用受激拉曼组织学(SRH)图像和公共基因组数据训练,用于弥漫性胶质瘤分子诊断。在前瞻性、多中心、国际测试队列(n=153)中,DeepGlioma预测WHO成人型弥漫性胶质瘤分类所需分子改变(IDH突变、1p19q共缺失、ATRX突变),平均分子分类准确率为93.3±1.6%。结果表明人工智能和光学组织学可作为湿实验室方法的快速可扩展辅助手段用于分子筛查。
要点
- DeepGlioma在90秒内基于SRH图像预测IDH突变、1p19q共缺失和ATRX突变。
- 前瞻性多中心国际测试队列n=153,平均分子分类准确率93.3±1.6%。
- 人工智能联合光学组织学可作为弥漫性胶质瘤分子筛查的快速可扩展辅助手段。
核心结论
- DeepGlioma可快速预测WHO成人型弥漫性胶质瘤分类所需的分子改变,作为湿实验室方法的快速可扩展辅助手段。
研究设计与样本
- 开发DeepGlioma,一种快速(<90秒)人工智能诊断筛查系统,使用包含受激拉曼组织学(SRH)和大型公共基因组数据的多模态数据集训练。
- 在前瞻性、多中心、国际测试队列的弥漫性胶质瘤患者(n=153)中进行实时SRH成像验证。
主要发现
- DeepGlioma预测IDH突变、1p19q共缺失和ATRX突变,平均分子分类准确率为93.3±1.6%。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Molecular classification has transformed the management of brain tumors by enabling more accurate prognostication and personalized treatment. However, timely molecular diagnostic testing for patients with brain tumors is limited, complicating surgical and adjuvant treatment and obstructing clinical trial enrollment. In this study, we developed DeepGlioma, a rapid (<90 seconds), artificial-intelligence-based diagnostic screening system to streamline the molecular diagnosis of diffuse gliomas. DeepGlioma is trained using a multimodal dataset that includes stimulated Raman histology (SRH); a rapid, label-free, non-consumptive, optical imaging method; and large-scale, public genomic data. In a prospective, multicenter, international testing cohort of patients with diffuse glioma (n = 153) who underwent real-time SRH imaging, we demonstrate that DeepGlioma can predict the molecular alterations used by the World Health Organization to define the adult-type diffuse glioma taxonomy (IDH mutation, 1p19q co-deletion and ATRX mutation), achieving a mean molecular classification accuracy of 93.3 ± 1.6%. Our results represent how artificial intelligence and optical histology can be used to provide a rapid and scalable adjunct to wet lab methods for the molecular screening of patients with diffuse glioma.
引用
- Hollon T, Jiang C, Chowdury A, et al. Artificial-intelligence-based molecular classification of diffuse gliomas using rapid, label-free optical imaging. Nat Med. 2023. PMID: 36959422. doi:10.1038/s41591-023-02252-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。